Prior Lung Inflammation Impacts on Body Distribution of Gold Nanoparticles

Figure 3

Body distribution of Au NPs with or without pretreatment with LPS. The concentration of Au NPs (μg·g⁻¹ relative organ weight) in lungs (a) in different secondary organs (b) of animals with or without pretreatment with LPS. ∗ represents statistically different from respective (saline/LPS) control group without NPs and † represents statistically different from NP-treated group without LPS, 𝑃<0.05 (two tailed). ***𝑃<0.01 and ^†††𝑃<0.01.